542 related articles for article (PubMed ID: 34402230)
1. Epidemiology and Clinical Features of Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in Korean Children: a Multicenter Study.
Park H; Yun KW; Kim KR; Song SH; Ahn B; Kim DR; Kim GB; Huh J; Choi EH; Kim YJ
J Korean Med Sci; 2021 Aug; 36(32):e232. PubMed ID: 34402230
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
3. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
[TBL] [Abstract][Full Text] [Related]
4. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
[TBL] [Abstract][Full Text] [Related]
5. Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.
Buchan SA; Alley S; Seo CY; Johnson C; Kwong JC; Nasreen S; Thampi N; Lu D; Harris TM; Calzavara A; Wilson SE
JAMA Pediatr; 2023 Apr; 177(4):410-418. PubMed ID: 36848096
[TBL] [Abstract][Full Text] [Related]
6. Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination-A nationwide study.
Su WJ; Liu YL; Chang CH; Lin YC; Huang WI; Wu LC; Chen SF; Lin YS; Hsieh YL; Yang CA; Lin CH; Chan KA; Lee PI; Chuang JH; Yang CH
J Microbiol Immunol Infect; 2023 Jun; 56(3):558-565. PubMed ID: 36804307
[TBL] [Abstract][Full Text] [Related]
7. Development of myocarditis and pericarditis after COVID-19 vaccination in children and adolescents: A systematic review.
Fatima M; Khan MHA; Ali MS; Osama M; Cheema HA; Ahmed A; Nisar A; Murad MW; Farooq H; Aemaz Ur Rehman M; Swed S; Akbar UA
Clin Cardiol; 2023 Mar; 46(3):243-259. PubMed ID: 36594165
[TBL] [Abstract][Full Text] [Related]
8. Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
Naveed Z; Li J; Wilton J; Spencer M; Naus M; Velásquez García HA; Kwong JC; Rose C; Otterstatter M; Janjua NZ;
J Am Coll Cardiol; 2022 Nov; 80(20):1900-1908. PubMed ID: 36357091
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barré Syndrome, and mortality in South Korea using a nationwide population-based cohort study.
Jeong HS; Chun BC
PLoS One; 2024; 19(2):e0297902. PubMed ID: 38381729
[TBL] [Abstract][Full Text] [Related]
10. Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents.
Schauer J; Buddhe S; Colyer J; Sagiv E; Law Y; Mallenahalli Chikkabyrappa S; Portman MA
J Pediatr; 2021 Nov; 238():317-320. PubMed ID: 34228985
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of myocarditis and pericarditis and reduced likelihood of severe clinical outcomes associated with COVID-19 vaccination: a cohort study in Lombardy, Italy.
Corrao G; Franchi M; Cereda D; Bortolan F; Leoni O; Vignati E; Pavesi G; Gori A
BMC Infect Dis; 2022 Nov; 22(1):844. PubMed ID: 36371165
[TBL] [Abstract][Full Text] [Related]
12. Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.
Yap J; Tham MY; Poh J; Toh D; Chan CL; Lim TW; Lim SL; Chia YW; Lim YT; Choo J; Ding ZP; Foo LL; Kuo S; Lau YH; Lee A; Yeo KK
Ann Acad Med Singap; 2022 Feb; 51(2):96-100. PubMed ID: 35224605
[TBL] [Abstract][Full Text] [Related]
13. Safety of BNT162b2 mRNA COVID-19 vaccine in children with chronic kidney disease: a national population study from South Korea.
Choe YJ; Ahn YH; Gwak E; Jo E; Kim J; Choe SA
Pediatr Nephrol; 2024 Feb; 39(2):625-629. PubMed ID: 37880380
[TBL] [Abstract][Full Text] [Related]
14. Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.
Chen C; Chen C; Cao L; Fang J; Xiao J
Int Immunopharmacol; 2024 May; 133():112022. PubMed ID: 38615382
[TBL] [Abstract][Full Text] [Related]
15. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
[TBL] [Abstract][Full Text] [Related]
16. Myocarditis and pericarditis following mRNA COVID-19 vaccination in younger patients: is there a shared thread?
Mormile R
Expert Rev Cardiovasc Ther; 2022 Feb; 20(2):87-90. PubMed ID: 35180029
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
Chua GT; Kwan MYW; Chui CSL; Smith RD; Cheung ECL; Ma T; Leung MTY; Tsao SSL; Kan E; Ng WKC; Chan VCM; Tai SM; Yu TC; Lee KP; Wong JSC; Lin YK; Shek CC; Leung ASY; Chow CK; Li KW; Ma J; Fung WY; Lee D; Ng MY; Wong WHS; Tsang HW; Kwok J; Leung D; Chung KL; Chow CB; Chan GCF; Leung WH; To KKW; Yuen KY; Lau YL; Wong ICK; Ip P
Clin Infect Dis; 2022 Sep; 75(4):673-681. PubMed ID: 34849657
[TBL] [Abstract][Full Text] [Related]
18. Myocarditis after vaccination against covid-19.
Gellad WF
BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
[No Abstract] [Full Text] [Related]
19. Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination.
Pastor Pueyo P; Gambó Ruberte E; Gayán Ordás J; Matute Blanco L; Pascual Figal D; Larrañaga Moreira JM; Gómez Barrado JJ; González Calle D; Almenar Bonet L; Alonso Salinas GL; Corbí Pascual MJ; Plaza Martín M; Pons Llinares J; Durante López A; Barreiro Pérez M; Candanedo Ocaña F; Bautista García J; Merchán Ortega G; Domínguez Rodríguez F; Martínez Mateo V; Campreciós Crespo M; Quintás Guzmán M; Jordán Martínez L; Aboal Viñas J; Rodríguez López J; Fernández Santos S; Revilla Martí P; Álvarez Roy L; Gómez Polo JC; García Pinilla JM; Ferré Vallverdú M; García Bueno L; Soriano Colomé T; Worner Diz F
Clin Res Cardiol; 2024 Feb; 113(2):223-234. PubMed ID: 37368015
[TBL] [Abstract][Full Text] [Related]
20. Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.
Chen C; Fu F; Ding L; Fang J; Xiao J
Front Immunol; 2022; 13():938322. PubMed ID: 36172346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]